Stockreport

Apollomics Reports First Half 2025 Financial Results

Apollomics Inc. - Class A Ordinary Shares  (APLM) 
PDF FOSTER CITY, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a late-stage clinical biopharmaceutical company [Read more]